Key Highlights
● Neogen closed at $12.73 on Tuesday, September 29, down 7.22% from the prior close of $13.72.
● The FDA issued warning letters to Neogen and contract manufacturer Sciarra Aeromed over fungal contamination in Neogen Vet HYCOAT.
● Nearly 100 horses developed serious joint infections and at least 20 were humanely euthanized, according to the FDA.
● Neogen began a voluntary recall in late January and reports Earnings October 6, followed by an investor day October 7.
Neogen Corporation (NASDAQ:NEOG) closed at $12.73 on Tuesday, September 29, 2026, a 7.22% decline from $13.72, on the day the US Food and Drug Administration issued warning letters over a veterinary product. The Nasdaq Composite eased only 0.09% to 26,797.54.
What the FDA Said
In an update dated September 29, the FDA said it had issued warning letters to Neogen and to Sciarra Aeromed, a contract manufacturer, over Neogen Vet HYCOAT, a hyaluronate sodium sterile solution. The product was labeled sterile but was contaminated with fungi, and reports of serious adverse events began arriving in late 2025.
The agency said nearly 100 horses developed serious joint infections and at least 20 were humanely euthanized, describing it as the largest number of horse deaths ever associated with a quality defect in an FDA-regulated veterinary medical product. Its inspection of the Manufacturing Facility found serious violations, including the manufacture of products labeled as sterile in a facility with insanitary conditions.
The Recall
Neogen began a voluntary recall of the product in late January 2026. A warning letter is a formal notice that the agency has found significant violations of federal requirements, and it asks the recipient to describe corrective actions.
Neogen's Financial Profile
Neogen's trailing twelve-month Revenue was $870.4 million, down 2.7%. The shares closed at $12.73 within a 52-week range of $5.37 to $14.26, leaving the stock about 11% below its yearly high and more than double its low.
Investor Day Comes Next
The warning letter arrives ahead of two company events on consecutive days: the earnings report on October 6 and the investor day on October 7. Neogen shares closed 7.22% lower on Tuesday, the day the FDA's update was dated.



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...